- A Mom Said Infant Formula Killed Her Baby. The Manufacturer Didn’t Tell the FDA.
- HealthQ Special: Caregiving in the Sandwich Generation
- New Disease Threats Follow Trump Administration’s Health Program Cuts
- Author Health expands mental health, dementia care services
- PDS Health opened 5 de novo offices in June
- Heartland Dental added 6 de novo offices in June
- Hospital groups push back on tax-exempt hospital bill: 9 things to know
- What other health systems could borrow from HCA, per an incoming hospital CEO
- CMS seeks new powers to remove ‘problematic’ Medicare providers — 8 things to know
- Why Northwell didn’t rush the Nuvance rebrand
- VCU Health taps president for planned hospital
- VA undersecretary resigns after less than 1 year
- What happens when ‘clinician in the loop’ makes AI worse?
- Children’s Hospital Colorado launches new brand campaign
- Why Physicians Belong in the Mid-Revenue Cycle
- Vanderbilt surgeons 1st in US to perform surgery with imaging tech
- AANA withdraws ‘nurse anesthesiologist’ trademark applications after ASA opposition
- 10 notes on dental M&A in 2026
- Dental implant manufacturer hit with ransomware attack
- Cedars-Sinai taps new head of ENT surgery
- 15 new ASCs in June
- The contract red flags behind Erlanger’s $21M Stark law case
- Premier Anesthesia, Hughston Clinic partner to expand orthopedic surgery access
- Physician gets $6.8M verdict in lawsuit against former employer
- Specialized Dental Partners adds Kentucky periodontics practice
- Seva Dental adds Ohio practice to network
- Vitana Pediatric & Orthodontic Partners adds New Jersey practice
- Delta Dental of Washington faces class-action lawsuit over reimbursements
- Tennessee Heart converts to independent model
- How this anesthesia residency built its own ASC pipeline
- Hackers threaten to publish 1-800-Dentist files: 5 notes
- California’s school behavioral health reimbursement program stalls
- CMS mulls tougher Medicare enrollment rules to combat fraud as part of 2027 home health payment rule
- The specialties losing private practices fastest
- Tenpoint debuts cast of lively everyday objects to zoom in on blurry vision hassles in Yuvezzi ad
- CMS goes live with GLP-1 Bridge program for Part D beneficiaries
- New Connecticut law expands Yale psychedelic-assisted therapy pilot
- What really breaks physician partnerships?
- The missing piece in crisis care? A model that avoided 1,580 ED days
- Align Technology faces antitrust probe from European Union: 8 things to know
- FDA Scientists Warn Against Expanded Peptide Access As Kennedy Reshapes Advisory Panel
- Lonza expands partnership with US drugmaker, boosts capacity for ADCs
- Trump administration withholds funds from New York's Medicaid fraud unit
- Alcohol accounts for 74% of substance use inpatient stays: 4 things to know
- Sanofi unit in Ireland chided by FDA over manufacturing flubs linked to Altuviiio
- Regulatory tracker: FDA sets decision date for Sarepta's DMD drugs
- Can A Popular Muscle Supplement Help Treat Depression?
- Zelis rolls out AI solution to help payers navigate No Surprises Act dispute process
- BridgeBio attracts $1B in equity for new launches, but analyst smells M&A ‘dry powder’
- Melatonin Shows Promise As Safe, Cheap Painkiller, Review Concludes
- Heat Dome Coming: Tips To Stay Safe During Extreme Temps
- Diets That Lower Inflammation Might Cut Dementia Risk, Study Indicates
- Vitamins Might Be Key To Asthma Control In Children, Adults
- Kimball lays out $103M to bolster life sciences CDMO footprint across Europe, India
- Haleon teams up with Microsoft in 5-year AI pact to upgrade consumer health operations
- ACCESS Model: behavioral health edition
- Would Hunters Take A Lyme Disease Vaccine? We Asked
- Affordable Healthcare Emerges as a Voter Priority in Purple Nevada
- Newsom Vowed To Transform Kids’ Mental Health. Many California Schools Are Still Waiting.
- Plus Therapeutics rebrands as Cerenome as it deepens AI strategy
- Orca Bio makes a splash with FDA approval for cell therapy Tregzi. Could an IPO come next?
- Colorado system transitions behavioral health crisis center to walk-in model
- Columbia, Weill Cornell secure $17.25M for profound autism research
- 16 state behavioral health policy updates
- Kansas bans kratom, 7-OH
- Remarks at the Economic Club of New York
- Evernorth unveils new AI-powered specialty pharmacy program, Pharmacy Forward
- Pediatric cannabis exposures rose 6,000% since 2009: 5 things to know
- 26 states sue CMS over final Medicaid work requirements rule
- Startup Queue lands $12.6M to launch autonomous robotic pharmacy kiosks
- Carbon Health agrees to revise contracts with its California clinics, pay penalties
- Experity acquires Exdion Healthcare to accelerate on-demand care RCM automation
- AstraZeneca agrees to pay $34M to settle 'free nurses' kickback lawsuit from Texas
- From Caffeine To 'Healthy' Labeling, FDA Sets Year-End Agenda For US Food Supply
- A 40-Year-Old Law Requires ERs To Treat Everyone — Unless They Opt Out
- Major Study Supports Same-Day COVID-19 and Flu Vaccination
- American Hospital Association names Steve Walsh as next CEO
- Medical journal retracts Tavneos pivotal study article, complicating Amgen’s defense effort
- Hyro rolls out analytics platform to glean insights from AI agent interactions
- Women With Parkinson's More Likely To Have Brain Changes Related To Alzheimer's
- Even Mild Weather Changes Impact Mental Health
- Breastfeeding Might Lower ADHD Risk, Study Finds
- After monotherapy failure, AbbVie and Genmab tout Epkinly combo win in DLBCL
- FDA selects Lilly, Regeneron, Fujifilm, 4 others for PreCheck Pilot Program
- She Struggled To Get A Lifesaving Drug Even After Insurers Vowed To Help
- Trouble Getting Weight Loss Drugs Covered By Insurance? Here's What To Know
- Would Hunters Take a Lyme Disease Vaccine? We Asked
- These Church Members Disagree on Politics. Together They’re Wiping Out Medical Debt.
- He Dreamed of Becoming a Physician Assistant. New Loan Rules May Thwart Him.
- Unicycive turned away by FDA again over manufacturer’s plant shortfalls
- Roche tops oncology reputation rankings as AstraZeneca climbs back to 2nd place
- Rising Stars: How Novo Nordisk’s Tara Sparks Went from Super Bowl Fan to Super Bowl Marketer
- Rural residents falling behind urban and suburban communities on medical, cancer screenings
- CMI Media Group bridges gaps in pharma marketing tech with newly launched Ad Astra platform
- How payers, drugmakers can collaborate to drive more outcomes-based contracts
- BeOne’s Brukinsa hits goal in mantle cell lymphoma confirmatory trial
- HRSA opens applications for $140M in rural health grant funding
- ACA marketplace enrollment down by 3M as of February, new federal data show
- Cases Of Rare But Dangerous Powassan Tick Virus Rising In U.S.
- Nearly 3 in 10 Young Adults Don't Have a Regular Doctor, Survey Finds
- Clinic network CEO pleads guilty to embezzling millions for 'social media influenced' market trading
- AI playing a major role in consumers' healthcare decision-making, survey finds
- Zymeworks acquires struggling Theravance for $929M
- Is Your Organization Ready to Govern AI in Regulatory Affairs?
- Klick bags Oxford PharmaGenesis in 3rd takeover in 18 months
- FDA rejects Sobi’s gout drug over manufacturing issues, sparing Amgen blockbuster
- Fertility Preservation Often Overlooked In Women's Cancer Care, Review Finds
- Sedatives Pose Fall Hazard For Recently Hospitalized Seniors
- Fourth Of July Poses Burn Hazards — Here's How To Protect Kids
- Efforts To End School Vaccine Mandates Hit A Wall In Florida
- A Dog's Stride Could Be An Early Sign Of Dementia, Study Says
- She Struggled To Get a Lifesaving Drug Even After Insurers Vowed To Help
- Florida Hospitals Act Fast To Discharge Gun Victims — Especially if They’re Not Insured
- Look out, Amgen. Here comes Viridian with FDA nod for TED med Lumvoa
- Doctronic, Simple HealthKit partner to connect at-home screening with AI-powered clinical care
- HHS announces new oversight measures for TEFCA, touts 1B health records exchanged
- Cancer Drug Shortage Renews Calls For Federal Action
- 3 in 10 adults turn to AI or social media for health advice, citing difficulties accessing and affording care
- Next-Generation Blood Test Improves Detection Of Aggressive Prostate Cancer
- Saint Peter’s Healthcare System Expands Intelligent Hospital Room Initiative with hellocare.ai to Advance AI Assisted Patient Safety and Virtual Care
- One Brooklyn Health Selects hellocare.ai to Advance AI-Powered Virtual Care Across Its Hospitals
- As PBM industry shifts, LucyRx and Abarca Health merge to build scale
- Most Patients Want Docs To Break Cancer News Directly, Not Through Portal Messaging
- Statins Rarely Cause Severe Muscle Problems, Researchers Say
- Even In Blue States, Hospitals Continue To Drop Gender-Affirming Care For Youths
- Younger U.S. Generations Increasingly Fear Adulthood, Study Says
- Opioid Settlement Money Pays For Services To Battle Addiction In Rural Kentucky
- Air Force Outbreak Grows As Military Reinstates Flu-Shot Rule For Recruits
- GLP-1 Weight-Loss Boom Linked To Surge In Poison Control Calls
- Brain Scans Improve Targeting Of Magnetic Stimulation For Depression
- Estrogen Birth Control May Protect Women’s Brains As They Age
- Very Few Men Discuss Prostate Cancer Screening With Their Doctor
- Severe Pregnancy Nausea Tied To Higher Risk Of Complications
- A Ban Won't Stop Abortion Pill Access, Telehealth Providers Say
- UnitedHealth, Humana And CVS Denied Post-Hospital Care At Some Of The Highest Rates
- Even 5-Minute Movement Breaks Can Boost Your Mood And Fight Fatigue
- Belly Laughs Spring From The Primitive Brain, Researchers Say
- Mom's Good Heart Health Lowers Risk Of Baby's Developmental Delays
- CMS Proposes TAVR Medicare Coverage is Potential Boost for Edwards Lifesciences
- Real-world data powers next-gen biopharma
- Remarks to the US-CEE Connection: Transatlantic Challenges in Law, Business & Policy
- Statement Regarding Minimum Pricing Increments and Access Fee Caps
- Statement at the SEC Open Meeting on the Trade-Through Rule and Locked and Crossed Markets Provisions of Regulation NMS
- Disorder Protection Rule: Statement on the Proposed Amendments to Rule 611 and Other Provisions of Regulation NMS
- Statement on the Proposed Amendments to Regulation NMS
- This Old House: Improving and Remodeling Our Registered Offering and Filer Status Regimes
- Peirce Out: Remarks at the U.S. Chamber of Commerce Capital Markets Summit
- Medtronic Advances Hugo Robotic Surgery Platform with Key FDA Filings and Product Approvals
- Medtronic Posts Strongest Revenue Growth in a Decade, Driven by Cardiovascular and Surgical Businesses
- Boston Scientific Plans Indiana Distribution Center, 300 New Jobs
Michigan healthcare freedom community forum
The US Attorney's Office reports on the case decided in Michigan's US Court, Eastern Division.
Interestingly, pain patients in Michigan are skeptical, saying they've never seen or heard of patient recruitment in real life. Only in investigations.
Southfield Doctor Sentenced to Six Years in Prison for Illegally Prescribing More Than 200,000 Opioid pills worth more than $5.2 million
Wednesday, September 24, 2025For Immediate ReleaseU.S. Attorney's Office, Eastern District of MichiganDETROIT –Dr. Charise Valentine, 69, of Southfield, was sentenced today to six years in prison based on her conviction following a jury trial on charges of conspiracy to unlawfully distribute prescription opioids, including Oxycodone and Oxymorphone, and 10 counts of illegal distribution of Oxycodone and Oxymorphone, United States Attorney Jerome F. Gorgon, Jr. announced.
Gorgon was joined in the announcement by Acting Special Agent in Charge Reuben Coleman, Federal Bureau of Investigation, Detroit Division, and Special Agent in Charge Mario Pinto of the U.S. Department of Health and Human Services Office of Inspector General’s (HHS-OIG) Chicago Regional Office.
Valentine was sentenced by U.S. District Judge Terrence G. Berg, who presided over the trial. The charges on which she was convicted and sentenced stemmed from her role as one of two doctors at Orthopedic Medical Building who issued illegal opioid prescriptions. From November 2016 to July 2018, Valentine issued more than 3,000 prescriptions for more than 200,000 pills to supposed “patients” who did not have a legitimate medical need for the drugs. Her co-defendant, Dr. Michele Ritter, also illegally issued thousands of opioid prescriptions.
Most “patients” were brought to the clinic by “patient recruiters/marketers.” Orthopedic Medical Building, a sham clinic that operated out of a warehouse in Oak Park, Michigan, was a cash-only “clinic,” and charged patients $200-500 per prescription, but did not charge anything if the patient didn’t receive an opioid prescription. As is common in illegal cash-only clinics, the prices were not based on the supposed service provided, but instead based on the quantity, type, and dosage of prescription opioids that the “patient” received, usually Oxycodone 30mg or Oxymorphone 40mg, two of the most addictive prescription opioids. These prescription drugs are also among the most highly diverted prescription opioids due to their high street value. The clinic also charged cash for the creation of fraudulent medical records for the supposed “patients.”
Dr. Valentine was paid about 50% of the clinic’s proceeds – more than $500,000 in cash over about 19 months – and she was paid only if she wrote an opioid prescription to a patient, not based on any supposed “medical care.” She received an envelope of thousands in cash each day she worked.
The other defendants charged in the case, including clinic operator Iris Winchester, Dr. Michele Ritter, and recruiter Joyce Robinson previously pleaded guilty and were sentenced to prison.
“Doctors take an oath to heal, not poison. As a doctor, this defendant knew better than anyone the devastating harm that opioid addiction causes to people. There is no place in our community for corrupt doctors,” said Gorgon.
“Dr. Valentine’s sentencing sends a clear message that the FBI will not tolerate any medical professional who stands to gain personally from abusing their position and endangering the public by illegally prescribing opioids,” said Reuben Coleman, Acting Special Agent in Charge of the FBI in Michigan. “We are grateful for our strong partnership with the U.S. Department of Health and Human Services – Office of Inspector General throughout the entire investigation, and we remain in lockstep with our partners on pursuing these fraudulent medical schemes to save countless lives.”
“As today’s sentencing demonstrates, physicians who endanger patients and engage in the unlawful distribution of prescription opioids will be held accountable,” said Special Agent in Charge Mario M. Pinto of the U.S. Department of Health and Human Services Office of Inspector General (HHS-OIG). “Our agency will continue to work in concert with our law enforcement partners to protect patients and the integrity of our federal health care programs.”
This case was prosecuted by Assistant United States Attorneys Andrew J. Lievense and Wayne F. Pratt. The Eastern District of Michigan is one of the twelve districts included in the Opioid Fraud Abuse and Detection Unit, a Department of Justice initiative that uses data to target and prosecute individuals that are contributing to the nation’s opioid crisis.
The case was investigated by special agents and task force officers of the Federal Bureau of Investigation and the Department of Health and Human Services-Office of the Inspector General.
Updated September 24, 2025
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.






















